Global Assets Advisory LLC Acquires New Shares in UnitedHealth Group Incorporated (NYSE:UNH)

Global Assets Advisory LLC purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 570,990 shares of the healthcare conglomerate’s stock, valued at approximately $282,469,000. UnitedHealth Group accounts for about 0.9% of Global Assets Advisory LLC’s investment portfolio, making the stock its 24th largest holding. Global Assets Advisory LLC owned 0.06% of UnitedHealth Group at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the stock. Richelieu Gestion SA purchased a new position in UnitedHealth Group in the 4th quarter worth $26,000. CGC Financial Services LLC increased its position in shares of UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 50 shares during the period. True Wealth Design LLC bought a new stake in UnitedHealth Group during the fourth quarter worth about $31,000. LFA Lugano Financial Advisors SA lifted its stake in shares of UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 40 shares in the last quarter. Finally, Transcendent Capital Group LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth approximately $40,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

UNH stock opened at $489.99 on Tuesday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. The company has a 50-day moving average price of $497.89 and a 200 day moving average price of $503.21. The stock has a market cap of $450.98 billion, a PE ratio of 29.95, a P/E/G ratio of 1.40 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the company earned $6.26 EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.57 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th will be given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.71%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date of this dividend is Monday, June 17th. UnitedHealth Group’s payout ratio is 51.34%.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the stock. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price objective on the stock in a research report on Wednesday, June 5th. Bank of America reissued a “buy” rating and issued a $675.00 price objective on shares of UnitedHealth Group in a research note on Thursday, March 7th. TD Cowen decreased their price objective on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Royal Bank of Canada decreased their price objective on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 17th. Finally, Piper Sandler lifted their price target on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Three investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $579.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.